Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» BioMarin's Morquio A drug confers "modest" benefit -FDA review
BioMarin's Morquio A drug confers "modest" benefit -FDA review
BioMarin's Morquio A drug confers "modest" benefit -FDA review
Submitted by
admin
on November 15, 2013 - 9:04am
Source:
Yahoo/Reuters
News Tags:
Biomarin
Morquio A Syndrome
FDA
Vimizim
Headline:
BioMarin's Morquio A drug confers "modest" benefit -FDA review
Do Not Allow Advertisers to Use My Personal information
